New Bioavailability and Bioequivalence Lab Leads the Way in the Philippines

Challenge

With the global bioanalytical testing services market size exceeding USD 2.7 billion, major pharmaceutical companies are outsourcing research and development activities so that they can focus on their core competencies and achieve economic efficiency.

Recognizing this growing demand in the Philippines, they saw the need to set up a bioavailability and bioequivalence (BA/BE) laboratory. As this required substantial investment and technical resource expertise, our customer reached out to us to help them plan, design, and install the lab.

The new lab had to also be in full compliance with both international and local Food and Drug Administration regulations.

Approach

Using our vast industry experience working with BA/BE labs and analysis equipment, our project team took a customer-centric approach to fully understand the company’s needs, its processes, desired methods required applications, and displayed a strong commitment to helping them meet their objectives.

The integrated solutions we proposed were from Agilent InfinityLab and the equipment used included liquid chromatography and mass spectrometry. Agilent is renowned for its high-performance analytical capability for a wide range of applications to help labs achieve the highest operational efficiency.

Complete workflows feature sample preparation, chromatography, mass spectrometry and software to acquire high-quality data, and turn it into definitive answers.

Result

After the installation of the BA/BE laboratory, the lab has successfully strengthened its position as one of the leading third-party testing laboratories in the market. It continues to grow its reputation for its unmatched productivity and performance in the pharmaceutical industry in the Philippines.